Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R.
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Leuk Res. 2014; 38(4):475-483
Doi: 10.1016/j.leukres.2014.01.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Linkesch Werner
-
Theiler Georg
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Recent data suggest that azacitidine may be beneficial in CMML. We report on 48 CMML-patients treated with azacitidine. Overall response rates were high (70% according to IWG-criteria, including 22% complete responses). Monocyte count and cytogenetics adversely affected survival, whereas age, WHO-type, FAB-type, and spleen size did not. Matched-pair analyses revealed a trend for higher two-year-survival for azacitidine as compared to best supportive care (62% vs. 41%, p=0.067) and longer OS for azacitidine first-line vs. hydroxyurea first-line (p=0.072, median OS 27.7 vs. 6.2 months). This report reinforces existing evidence that azacitidine is safe and efficacious in both myelodysplastic and myeloproliferative CMML.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
-
Activities of Daily Living -
-
Adult -
-
Aged -
-
Aged, 80 and over -
-
Antimetabolites, Antineoplastic - therapeutic use
-
Azacitidine - therapeutic use
-
Disease Progression -
-
Female -
-
Humans -
-
Leukemia, Myelomonocytic, Chronic - drug therapy
-
Leukemia, Myelomonocytic, Chronic - mortality
-
Male -
-
Matched-Pair Analysis -
-
Middle Aged -
-
Survival Analysis -
- Find related publications in this database (Keywords)
-
Matched-pair analysis
-
CMML
-
Chronic myelomonocytic leukemia
-
Azacitidine
-
Austrian Azacitidine Registry